BRIEF-Com Hem Q1 operating profit increases
* Q1 revenue saw a increase of 37.7% to SEK 1,757m while organic revenue rose by 3.5% to SEK 1,321m.
Oct 4 (Reuters) -
* HHS sponsors commercial manufacturing tests for Ebola vaccine
* HHS says contract could be extended for up to a total of five years and $75.98 million to support additional safety studies
* HHS says ebola vaccine will take next critical steps in development under $24.8 million contract between U.S. HHS and BioProtection systems